Review of the evidence: Prevalence of medical conditions in the United States population with serious mental illness

Ellen M. Janssen, Emma Beth McGinty, Susan T. Azrin, Denise Juliano-Bult, Gail L Daumit

Research output: Contribution to journalArticle

Abstract

Objective: Persons with serious mental illness (SMI) have high rates of premature mortality from preventable medical conditions, but this group is underrepresented in epidemiologic surveys and we lack national estimates of the prevalence of conditions such as obesity and diabetes in this group. We performed a comprehensive review to synthesize estimates of the prevalence of 15 medical conditions among the population with SMI. Method: We reviewed studies published in the peer-reviewed literature from January 2000 to August 2012. Studies were included if they assessed prevalence in a sample of 100 or more United States (US) adults with schizophrenia or bipolar disorder. Results: A total of 57 studies were included in the review. For most medical conditions, the prevalence estimates varied considerably. For example, estimates of obesity prevalence ranged from 26% to 55%. This variation appeared to be due to differences in measurement (e.g., self-report versus clinical measures) and underlying differences in study populations. Few studies assessed prevalence in representative, community samples of persons with SMI. Conclusions: In many studies, the prevalence of medical conditions among the population with SMI was higher than among the overall US population. Screening for and monitoring of these conditions should be common practice in clinical settings serving persons with SMI.

Original languageEnglish (US)
Pages (from-to)199-222
Number of pages24
JournalGeneral Hospital Psychiatry
Volume37
Issue number3
DOIs
StatePublished - May 1 2015

Fingerprint

Population
Obesity
Cross-Sectional Studies
Premature Mortality
Bipolar Disorder
Self Report
Schizophrenia
Surveys and Questionnaires

Keywords

  • Bipolar disorder
  • Medical co-morbidity
  • Prevalence
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Review of the evidence : Prevalence of medical conditions in the United States population with serious mental illness. / Janssen, Ellen M.; McGinty, Emma Beth; Azrin, Susan T.; Juliano-Bult, Denise; Daumit, Gail L.

In: General Hospital Psychiatry, Vol. 37, No. 3, 01.05.2015, p. 199-222.

Research output: Contribution to journalArticle

@article{2b87078f618345b48a843902dd7c97fd,
title = "Review of the evidence: Prevalence of medical conditions in the United States population with serious mental illness",
abstract = "Objective: Persons with serious mental illness (SMI) have high rates of premature mortality from preventable medical conditions, but this group is underrepresented in epidemiologic surveys and we lack national estimates of the prevalence of conditions such as obesity and diabetes in this group. We performed a comprehensive review to synthesize estimates of the prevalence of 15 medical conditions among the population with SMI. Method: We reviewed studies published in the peer-reviewed literature from January 2000 to August 2012. Studies were included if they assessed prevalence in a sample of 100 or more United States (US) adults with schizophrenia or bipolar disorder. Results: A total of 57 studies were included in the review. For most medical conditions, the prevalence estimates varied considerably. For example, estimates of obesity prevalence ranged from 26{\%} to 55{\%}. This variation appeared to be due to differences in measurement (e.g., self-report versus clinical measures) and underlying differences in study populations. Few studies assessed prevalence in representative, community samples of persons with SMI. Conclusions: In many studies, the prevalence of medical conditions among the population with SMI was higher than among the overall US population. Screening for and monitoring of these conditions should be common practice in clinical settings serving persons with SMI.",
keywords = "Bipolar disorder, Medical co-morbidity, Prevalence, Schizophrenia",
author = "Janssen, {Ellen M.} and McGinty, {Emma Beth} and Azrin, {Susan T.} and Denise Juliano-Bult and Daumit, {Gail L}",
year = "2015",
month = "5",
day = "1",
doi = "10.1016/j.genhosppsych.2015.03.004",
language = "English (US)",
volume = "37",
pages = "199--222",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Review of the evidence

T2 - Prevalence of medical conditions in the United States population with serious mental illness

AU - Janssen, Ellen M.

AU - McGinty, Emma Beth

AU - Azrin, Susan T.

AU - Juliano-Bult, Denise

AU - Daumit, Gail L

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Objective: Persons with serious mental illness (SMI) have high rates of premature mortality from preventable medical conditions, but this group is underrepresented in epidemiologic surveys and we lack national estimates of the prevalence of conditions such as obesity and diabetes in this group. We performed a comprehensive review to synthesize estimates of the prevalence of 15 medical conditions among the population with SMI. Method: We reviewed studies published in the peer-reviewed literature from January 2000 to August 2012. Studies were included if they assessed prevalence in a sample of 100 or more United States (US) adults with schizophrenia or bipolar disorder. Results: A total of 57 studies were included in the review. For most medical conditions, the prevalence estimates varied considerably. For example, estimates of obesity prevalence ranged from 26% to 55%. This variation appeared to be due to differences in measurement (e.g., self-report versus clinical measures) and underlying differences in study populations. Few studies assessed prevalence in representative, community samples of persons with SMI. Conclusions: In many studies, the prevalence of medical conditions among the population with SMI was higher than among the overall US population. Screening for and monitoring of these conditions should be common practice in clinical settings serving persons with SMI.

AB - Objective: Persons with serious mental illness (SMI) have high rates of premature mortality from preventable medical conditions, but this group is underrepresented in epidemiologic surveys and we lack national estimates of the prevalence of conditions such as obesity and diabetes in this group. We performed a comprehensive review to synthesize estimates of the prevalence of 15 medical conditions among the population with SMI. Method: We reviewed studies published in the peer-reviewed literature from January 2000 to August 2012. Studies were included if they assessed prevalence in a sample of 100 or more United States (US) adults with schizophrenia or bipolar disorder. Results: A total of 57 studies were included in the review. For most medical conditions, the prevalence estimates varied considerably. For example, estimates of obesity prevalence ranged from 26% to 55%. This variation appeared to be due to differences in measurement (e.g., self-report versus clinical measures) and underlying differences in study populations. Few studies assessed prevalence in representative, community samples of persons with SMI. Conclusions: In many studies, the prevalence of medical conditions among the population with SMI was higher than among the overall US population. Screening for and monitoring of these conditions should be common practice in clinical settings serving persons with SMI.

KW - Bipolar disorder

KW - Medical co-morbidity

KW - Prevalence

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84930180762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930180762&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2015.03.004

DO - 10.1016/j.genhosppsych.2015.03.004

M3 - Article

C2 - 25881768

AN - SCOPUS:84930180762

VL - 37

SP - 199

EP - 222

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

IS - 3

ER -